A- A A+

UK. Drug workers warn heroin treatment shortage will cost lives

An "unprecedented shortage" of a substitute for illegal heroin in England is putting hundreds of lives at risk, say drug workers. (BBC, UK, 11.06.2022)

https://www.bbc.com/news/health-61699960

Schweiz. Heroin made in Switzerland. 

Reines Heroin aus der Schweiz. Das gibt es ganz legal. Schon seit fast 30 Jahren. Der Produktionsort ist höchst geheim. Der Hersteller will anonym bleiben. Input Redaktor Samuel Emch hat den Schweizer Heroinproduzenten aufgespürt und mit Ihm über sein heikles Geschäft gesprochen. 

SRF – Schweizerischer Rundfunk, Autor:in: Samuel Emch, Moderation: Samuel Emch, Redaktion: Samuel Emch, 27.03.2022, 40:00)

https://www.srf.ch/audio/input/heroin-made-in-switzerland?id=12164789

Switzerland's Dependence on a Diamorphine Monopoly. 

Schmitt-Koopmann C, Baud CA, Junod V, Simon O. 

Front Psychiatry. 2022 May 9;13:882299. doi: 10.3389/fpsyt.2022.882299. PMID: 35615450; PMCID: PMC9125182.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125182/

UK. Pushed to the Brink

Three years ago, nine people in the South West of England were going about their daily lives, just as anyone else might, juggling jobs and family life with all the everyday ups and downs. 

Each of them was in regular receipt of a diamorphine (heroin) script, which was working well for them in managing their dependence on opiates and giving them a good quality of life.

Then came a letter from their treatment provider – the same letter to each of them, with just their names changed. In line with ‘best practice’ they must have their treatment changed. They needed to choose a different option – oral methadone, MXL (slow-release morphine tablets), or inpatient rehab.

Four of the nine patients decided they had to challenge the decision. Jill and Helen (not their real names) talked to us about what happened and how it affected them. (DDN – Drink and Drugs News, UK, 02.05.2022)

https://www.drinkanddrugsnews.com/pushed-to-the-brink

Sexual Dysfunctions in Patients Receiving Opioid Agonist Treatment and Heroin-Assisted Treatment Compared to Patients in Private Practice-Identifying Group Differences and Predictors. 

Meyer M, Brunner P, Geissmann L, Gürtler M, Schwager F, Waldis R, Vogel M, Wiesbeck GA, Dürsteler KM. 

Front Psychiatry. 2022 Mar 22;13:846834. doi: 10.3389/fpsyt.2022.846834. PMID: 35392381; PMCID: PMC8980546.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980546/

Diamorphingestützte Behandlung in Deutschland

Gemeinsame Website der Ambulanzen und Praxen in Deutschland, die Diamorphin zur Opioidsubstitution anbieten. (Stand April 2022)

http://www.diamorphin-behandlung.de/

Schweiz. Situationsanalyse der heroingestützten Behandlung (HeGeBe).

Frey, Kathrin; Pestoni, Amélie; Häusermann, Marina (2021) 

Zürich: KEK – CDC.

https://www.bag.admin.ch/dam/bag/en/dokumente/e-f/evalber-ncd-sucht/2021-situationsanalyse-hegebe-schlussbericht.pdf.download.pdf/2021-schlussbericht-situationsanalyse-hegebe-d.pdf

Schweiz. Substitutionsgestützte Behandlung mit Diacetylmorphin (Heroin)

Die substitutionsgestützte Behandlung mit Diacetylmorphin (pharmazeutisch hergestelltes Heroin) richtet sich an Personen mit schwerer Heroinabhängigkeit und erfolgt in Fachzentren. 

Die diacetylmorphingestützte Behandlung (heroingestützte Behandlung, kurz HeGeBe) beinhaltet eine strikt reglementierte und kontrollierte Verabreichung von Diacetylmorphin, eingebettet in eine ärztliche und psychosoziale Betreuung. Sie wurde in der Schweiz 1994 im Rahmen einer Kohortenstudie erstmals durchgeführt. Nach positiven Ergebnissen etablierte sie sich als therapeutische Massnahme und wurde bei der Revision von 2011 im Betäubungsmittelgesetz verankert. 2020 wurden rund 1’600 Abhängige in 22 ambulanten Fachzentren und 1 Strafvollzugsanstalt behandelt. In der Schweiz erhalten rund 8 Prozent der Personen mit Opioidabhängigkeit eine substitutionsgestützte Behandlung mit Diacetylmorphin.

Bewilligungen, Aufsicht, Kontrolle und Information zu dieser Behandlung sind Sache des BAG (Bundesamt für Gesundheit, Anm.). (BAG – Bundesamt für Gesundheit, Schweiz, Themenseite, Stand 22.04.2022)

https://www.bag.admin.ch/bag/de/home/gesund-leben/sucht-und-gesundheit/suchtberatung-therapie/substitutionsgestuetzte-behandlung/heroingestuetzte-behandlung.html

Exploring why patients in heroin-assisted treatment are getting incarcerated-a qualitative study. 

Meyer M, Rist B, Strasser J, Lang UE, Vogel M, Dürsteler KM, Walter M. 

BMC Psychiatry. 2022 Mar 7;22(1):169. doi: 10.1186/s12888-022-03814-5. PMID: 35255853; PMCID: PMC8903629.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903629/

N Diacetylmorphine Hydrochloride: PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION

Diamorphine hydrochloride for injection, Powder, 200 mg per vial, 5 g per vial, intramuscular and intravenous injection. British Pharmacopoeia. Opioid agonist

PHARMASCIENCE INC., 6111 Royalmount Ave, Suite 100, Montreal, Quebec; H4P 2T4, Date of Initial Authorization: February 14, 2022, Submission Control Number: 254850

https://pdf.hres.ca/dpd_pm/00064756.PDF

«One prick and then it´s done»: a mixed-methods exploratory study on intramuscular injection in heroin-assisted treatment. 

Meyer M, Eichenberger R, Strasser J, Dürsteler KM, Vogel M. 

Harm Reduct J. 2021 Dec 18;18(1):134. doi: 10.1186/s12954-021-00584-3. PMID: 34922561; PMCID: PMC8684658.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684658/

Kanada. B.C. doctors upset their ‘safe supply' of heroin going unprescribed during overdose crisis 

The doctors are asking the Ministry of Health to fund heroin-assisted treatment for 200 British Columbians at an average cost of $25 a day. (Vancouver Sun, Kanada, 15.12.2021)

https://vancouversun.com/news/b-c-doctors-upset-their-safe-supply-of-heroin-going-unprescribed-during-overdose-crisis

Fifteen years of heroin-assisted treatment in a Swiss prison-a retrospective cohort study. 

Liebrenz M, Gamma A, Buadze A, Schleifer R, Baggio S, Schwartz B, Schneeberger A, Uchtenhagen A. 

Harm Reduct J. 2020 Oct 13;17(1):67. doi: 10.1186/s12954-020-00412-0. PMID: 33046103; PMCID: PMC7552491.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552491/

Australien. The case for an Australian heroin trial: strong then, even stronger now

By Alex Wodak, Bob Douglas and David McDonald

Pearls and Irritations, 08.11.2021

https://johnmenadue.com/the-case-for-an-australian-heroin-trial-strong-then-even-stronger-now/

Köln. Tagesthemen-Reportage aus der Kölner Diamorphin-Ambulanz

(Tagesthemen, Mittendrin-Reportage, ARD, 11.10.2021, Video, 25:52 – 31:07)

https://www.ardmediathek.de/video/tagesthemen/das-erste/Y3JpZDovL2Rhc2Vyc3RlLmRlL3RhZ2VzdGhlbWVuLzNjOGE2ODY4LTFmMzctNGZhMS1hYjJjLTU0MmFhNDc5OTRkZg/

The suitability of oral diacetylmorphine in treatment-refractory patients with heroin dependence: A scoping review. 

F Martins ML, Wilthagen EA, Oviedo-Joekes E, Beijnen JH, de Grave N, Uchtenhagen A, Beck T, Van den Brink W, Schinkel AH. 

Drug Alcohol Depend. 2021 Oct 1;227:108984. doi: 10.1016/j.drugalcdep.2021.108984. Epub 2021 Aug 28. PMID: 34482044.

Abstract

https://pubmed.ncbi.nlm.nih.gov/34482044/

Kanada. Vancouver clinic revokes 11 patients’ access to take-home heroin doses

Eleven patients who were permitted to take home doses of medical-grade heroin from a Vancouver clinic have had the permission abruptly revoked.

The patients were told last week that they can continue ingesting the drug (diacetylmorphine) under medical supervision at the Providence Crosstown Clinic, but would no longer be able to carry a daily supply off-site, according to four patients who spoke with The Globe and Mail. They were cut off from receiving take-home doses – called “carries” – by weeks’ end and were not given a reason for the discontinuation. (Globe and Mail, Kanada, 27.09.2021)

https://www.theglobeandmail.com/canada/article-vancouver-clinic-revokes-11-patients-access-to-take-home-heroin-doses/

Kanada/British Columbia. Vancouver clinic first in North America to offer take-home medical-grade heroin

A safe supply of medical-grade heroin can be a lifeline for those battling opioid addiction. (CBC Canada, Kanada, 16.09.2021)

https://www.cbc.ca/news/canada/british-columbia/take-home-medical-heroin-1.6179280

Kanada. Prescription Inhalable Heroin Is Coming to BC. Will the Province Embrace It?

Experts say it’s past time to expand life-saving therapy for drug users. (The Tyee, Kanada, 17.09.2021)

https://thetyee.ca/News/2021/09/17/Prescription-Inhalable-Heroin-BC/

Nasal Opioid Agonist Treatment in Patients with Severe Opioid Dependence: A Case Series. 

Vogel M, Köck P, Strasser J, Kalbermatten C, Binder H, Dürsteler KM, Walter M, Falcato L, Krausz M, Kormann A. 

Eur Addict Res. 2021 Jul 26:1-6. doi: 10.1159/000516431. Epub ahead of print. PMID: 34311466.

Abstract

https://www.karger.com/Article/Abstract/516431

Heroin-Assisted Treatment and the United Nations international drug control apparatus

GDPO Working Paper Series Working Paper No. 7 (July 2021) - Christopher Hallam

https://www.swansea.ac.uk/media/GDPO_Working_Paper_on-HAT_FINAL.pdf

Heroin auf Rezept (Audio)

(WDR 5 Quarks - Topthemen aus der Wissenschaft. 18.09.2019. 06:32, verfügbar bis 17.09.2024.)

https://wdrmedien-a.akamaihd.net/medp/podcast/weltweit/fsk0/200/2005599/wdr5quarkstopthemenausderwissenschaft_2019-09-18_heroinaufrezept_wdr5.mp3

UK. Middlesbrough heroin addiction clinic secures funding until March

A scheme which gives supervised diamorphine injections to heroin addicts is to be extended after securing new funding. (BBC, UK, 08.2021)

https://www.bbc.com/news/uk-scotland-57748725

Schottland. Developing Heroin Assisted Treatment in Scotland – learning from current practice - SDF Webinar (Video)

The Scottish Government has made its intentions clear regarding the provision of Heroin Assisted Treatment across Scotland. This will add another important intervention in our response to the on-going public health emergency which is Scotland’s drug related deaths crisis. (SDF – Scottish Drugs Forum, Schottland, 28.06.2021, Video, 01:25:41)

https://www.youtube.com/watch?v=HWxpNwyIp2k

'Apprentissage de l’élargissement des modalités de prescription de l’héroïne médicale avec le Covid-19', 

Calzada, G., Giustiniani, J., Gois, T., Kuntz, A., Khazaal, Y., Zullino, D. (2021). 

Rev Med Suisse 2021; volume 7. no. 742, 1111 - 1114 doi: 

https://www.revmed.ch/revue-medicale-suisse/2021/revue-medicale-suisse-742/apprentissage-de-l-elargissement-des-modalites-de-prescription-de-l-heroine-medicale-avec-le-covid-19

Does Heroin-Assisted Treatment Reduce Crime? A Review of Randomized-Controlled Trials. 

Smart, R., and Reuter, P. (2021) 

Addiction, doi.org/10.1111/add.15601 

Abstract

https://onlinelibrary.wiley.com/doi/abs/10.1111/add.15601

Advocating for diamorphine: Cosmopolitical care and collective action in the ruins of the 'old British system'. 

Dennis F. 

Crit Public Health. 2021;31(2):144-155. doi: 10.1080/09581596.2020.1772463. Epub 2020 Jun 4. PMID: 34079177; PMCID: PMC7610880.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610880/

UK. Cleveland's new Police and Crime Commissioner says he won't continue funding Middlesbrough's Heroin Assisted Treatment

Cleveland's new Police and Crime Commissioner Steve Turner has been told he is "making a mistake" by ending funding from his office for a trailblazing heroin addiction treatment (HAT) scheme. (ITV, 18.05.2021)

https://www.itv.com/news/tyne-tees/2021-05-18/clevelands-new-police-and-crime-commissioner-says-he-wont-continue-funding-middlesbroughs-heroin-assisted-treatment

UK. Guidance: Injectable opioid treatment: commissioning and providing services 

Guidance on commissioning and providing injectable opioid treatment for people with opioid dependence who have not responded to oral treatment. (Government UK, Public Health England, 19.03.2021)

https://www.gov.uk/government/publications/injectable-opioid-treatment-commissioning-and-providing-services

Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scans. 

Eydt E, Glegg S, Sutherland C, Meador K, Trew M, Perreault M, Goyer MÈ, Le Foll B, Turnbull J, Fairbairn N. 

CMAJ Open. 2021 Feb 23;9(1):E115-E124. doi: 10.9778/cmajo.20200021. PMID: 33622764.

http://cmajopen.ca/content/9/1/E115.long